Allostery Investments’s Insmed INSM Stock Holding History

Allostery Investments’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-10,000	Closed	-$763K	–	30
2025 Q1	$763K	Hold	10,000	–	–	1.1%	22
2024 Q4	$690K	Buy	+10,000	New	+$720K	0.72%	24

Other funds holding INSM

DGM

Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Allostery Investments's INSM Position: Q2 2025 in Review

Allostery Investments sold out of Insmed (INSM) in Q2 2025, closing a stake of 10,000 shares — an estimated $763K sold.

Allostery Investments first reported a position in INSM in Q4 2024 and held it in 2 quarters. The position peaked at $763K in Q1 2025. 516 funds tracked by Wall St. Rank hold INSM as of Q2 2025.

Allostery Investments reported no remaining Insmed position as of Q2 2025 after selling out during the quarter.
Allostery Investments sold 10,000 Insmed shares in Q2 2025, an estimated $763K.
Allostery Investments first reported a position in Insmed in Q4 2024 and held it in 2 quarters.
Allostery Investments's Insmed position peaked at $763K in Q1 2025.
516 funds tracked by Wall St. Rank held Insmed as of Q2 2025.

Based on Allostery Investments's 13F filing for Q2 2025, filed 14 Aug 2025.